Long-term effects of nimodipine on pial microvasculature and systemic circulation in conscious rats

X. Q. Yuan, T. L. Smith, Donald Prough, Douglas Dewitt, J. W. Dusseau, C. D. Lynch, J. M. Fulton, P. M. Hutchins

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The chronic cranial window preparation allows repeated measurements of the same pial vessels in unanesthetized rats for several weeks and correlation with 24-h monitoring of hemodynamic variables. Nimodipine (20 mg) or placebo was given via two subcutaneous pellets. Large arterioles dilated 26 and 16%, at hour 1 and days 6-13, respectively (P<0.02). There was an increase in number of small arterioles throughout the whole observation period with the maximal increment of 47% (P<0.05) at days 6-13. Maximal vasodilation with 10% CO2 indicated that the increase in number of small arterioles after administering nimodipine was not caused by the opening of previously closed vessels. The total length of small arterioles and venules increased 47 and 23% at days 6-13, respectively (P<0.001). These increases seem to be caused by the increases in the numbers of vessels, because the average length of the small vessels did not appear to change. This suggests that nimodipine reduces cerebral vascular resistance by causing cerebral microvessel neovascularization. Our data demonstrate that the administration of nimodipine (20 mg) is potent in dilating pial arterioles in the short-term without affecting systemic arterial pressure, and that its long-term effect results in new vessel growth.

Original languageEnglish
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume258
Issue number5 27-5
StatePublished - 1990
Externally publishedYes

Fingerprint

Nimodipine
Arterioles
Microvessels
Venules
Vasodilation
Vascular Resistance
Arterial Pressure
Hemodynamics
Placebos
Observation
Growth

Keywords

  • angiogenesis
  • Brain
  • calcium channel blocker
  • cranial window
  • microcirculation
  • neovascularization

ASJC Scopus subject areas

  • Physiology

Cite this

Long-term effects of nimodipine on pial microvasculature and systemic circulation in conscious rats. / Yuan, X. Q.; Smith, T. L.; Prough, Donald; Dewitt, Douglas; Dusseau, J. W.; Lynch, C. D.; Fulton, J. M.; Hutchins, P. M.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 258, No. 5 27-5, 1990.

Research output: Contribution to journalArticle

@article{37b7e3315f224944a6b855ad40a6dad6,
title = "Long-term effects of nimodipine on pial microvasculature and systemic circulation in conscious rats",
abstract = "The chronic cranial window preparation allows repeated measurements of the same pial vessels in unanesthetized rats for several weeks and correlation with 24-h monitoring of hemodynamic variables. Nimodipine (20 mg) or placebo was given via two subcutaneous pellets. Large arterioles dilated 26 and 16{\%}, at hour 1 and days 6-13, respectively (P<0.02). There was an increase in number of small arterioles throughout the whole observation period with the maximal increment of 47{\%} (P<0.05) at days 6-13. Maximal vasodilation with 10{\%} CO2 indicated that the increase in number of small arterioles after administering nimodipine was not caused by the opening of previously closed vessels. The total length of small arterioles and venules increased 47 and 23{\%} at days 6-13, respectively (P<0.001). These increases seem to be caused by the increases in the numbers of vessels, because the average length of the small vessels did not appear to change. This suggests that nimodipine reduces cerebral vascular resistance by causing cerebral microvessel neovascularization. Our data demonstrate that the administration of nimodipine (20 mg) is potent in dilating pial arterioles in the short-term without affecting systemic arterial pressure, and that its long-term effect results in new vessel growth.",
keywords = "angiogenesis, Brain, calcium channel blocker, cranial window, microcirculation, neovascularization",
author = "Yuan, {X. Q.} and Smith, {T. L.} and Donald Prough and Douglas Dewitt and Dusseau, {J. W.} and Lynch, {C. D.} and Fulton, {J. M.} and Hutchins, {P. M.}",
year = "1990",
language = "English",
volume = "258",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "5 27-5",

}

TY - JOUR

T1 - Long-term effects of nimodipine on pial microvasculature and systemic circulation in conscious rats

AU - Yuan, X. Q.

AU - Smith, T. L.

AU - Prough, Donald

AU - Dewitt, Douglas

AU - Dusseau, J. W.

AU - Lynch, C. D.

AU - Fulton, J. M.

AU - Hutchins, P. M.

PY - 1990

Y1 - 1990

N2 - The chronic cranial window preparation allows repeated measurements of the same pial vessels in unanesthetized rats for several weeks and correlation with 24-h monitoring of hemodynamic variables. Nimodipine (20 mg) or placebo was given via two subcutaneous pellets. Large arterioles dilated 26 and 16%, at hour 1 and days 6-13, respectively (P<0.02). There was an increase in number of small arterioles throughout the whole observation period with the maximal increment of 47% (P<0.05) at days 6-13. Maximal vasodilation with 10% CO2 indicated that the increase in number of small arterioles after administering nimodipine was not caused by the opening of previously closed vessels. The total length of small arterioles and venules increased 47 and 23% at days 6-13, respectively (P<0.001). These increases seem to be caused by the increases in the numbers of vessels, because the average length of the small vessels did not appear to change. This suggests that nimodipine reduces cerebral vascular resistance by causing cerebral microvessel neovascularization. Our data demonstrate that the administration of nimodipine (20 mg) is potent in dilating pial arterioles in the short-term without affecting systemic arterial pressure, and that its long-term effect results in new vessel growth.

AB - The chronic cranial window preparation allows repeated measurements of the same pial vessels in unanesthetized rats for several weeks and correlation with 24-h monitoring of hemodynamic variables. Nimodipine (20 mg) or placebo was given via two subcutaneous pellets. Large arterioles dilated 26 and 16%, at hour 1 and days 6-13, respectively (P<0.02). There was an increase in number of small arterioles throughout the whole observation period with the maximal increment of 47% (P<0.05) at days 6-13. Maximal vasodilation with 10% CO2 indicated that the increase in number of small arterioles after administering nimodipine was not caused by the opening of previously closed vessels. The total length of small arterioles and venules increased 47 and 23% at days 6-13, respectively (P<0.001). These increases seem to be caused by the increases in the numbers of vessels, because the average length of the small vessels did not appear to change. This suggests that nimodipine reduces cerebral vascular resistance by causing cerebral microvessel neovascularization. Our data demonstrate that the administration of nimodipine (20 mg) is potent in dilating pial arterioles in the short-term without affecting systemic arterial pressure, and that its long-term effect results in new vessel growth.

KW - angiogenesis

KW - Brain

KW - calcium channel blocker

KW - cranial window

KW - microcirculation

KW - neovascularization

UR - http://www.scopus.com/inward/record.url?scp=0025338843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025338843&partnerID=8YFLogxK

M3 - Article

VL - 258

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 5 27-5

ER -